Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Please find enclosed transcript for the jagsonpal pharmaceuticals Limited Q2 FY 2026 earnings call held on November 04, 2025 at 2:00 P.M for discussion of Q2 FY26 Financial Results.
Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30, 2025